DIPROLENE AF SUMMARY
DIPROLENE® AF Cream 0.05% contains betamethasone dipropionate, USP, a synthetic adrenocorticosteroid, for dermatologic use in an emollient base. Betamethasone, an analog of prednisolone, has a high degree of corticosteroid activity and a slight degree of mineralocorticoid activity. Betamethasone dipropionate is the 17, 21-dipropionate ester of betamethasone.
DIPROLENE AF Cream 0.05% is a high-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older.
|
NEWS HIGHLIGHTSMedia Articles Related to Diprolene AF (Betamethasone Topical)
EU Approves Dupilumab (Dupixent) for Atopic Dermatitis Source: Medscape Allergy & Clinical Immunology Headlines [2017.09.28] The European Commission has granted marketing authorization to dupilumab for adults with moderate to severe atopic dermatitis, according to a company news release. International Approvals
Atopic Eczema (Atopic Dermatitis) Quiz: Test Your Skin Disorders IQ Source: MedicineNet Atopic Dermatitis Specialty [2017.09.20] Title: Atopic Eczema (Atopic Dermatitis) Quiz: Test Your Skin Disorders IQ Category: MedicineNet Quiz Created: 3/20/2012 12:50:00 PM Last Editorial Review: 9/20/2017 12:22:53 PM
Seborrheic Dermatitis Source: MedicineNet Eye Care Specialty [2017.08.09] Title: Seborrheic Dermatitis Category: Diseases and Conditions Created: 3/16/2012 12:00:00 AM Last Editorial Review: 8/9/2017 12:00:00 AM
Contact Dermatitis Source: MedicineNet hydrocortisone valerate Specialty [2017.06.09] Title: Contact Dermatitis Category: Symptoms and Signs Created: 4/1/2014 12:00:00 AM Last Editorial Review: 6/9/2017 12:00:00 AM
Atopic Dermatitis Source: MedicineNet betamethasone dipropionate Specialty [2016.12.21] Title: Atopic Dermatitis Category: Diseases and Conditions Created: 12/31/1997 12:00:00 AM Last Editorial Review: 12/21/2016 12:00:00 AM
Published Studies Related to Diprolene AF (Betamethasone Topical)
Chinese medicine combined with calcipotriol betamethasone and calcipotriol
ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized
controlled trial. [2014] BACKGROUND: Psoriasis causes worldwide concern because of its high-prevalence, as
well as its harmful, and incurable characteristics... DISCUSSION: To address the effectual remission of the YXBCM01 granule for PV,
this trial may provide a novel regimen for PV patients if the granule can
decrease relapse rate without more adverse effects.
Calcipotriene plus betamethasone dipropionate topical suspension for the
treatment of mild to moderate psoriasis vulgaris on the body: a randomized,
double-blind, vehicle-controlled trial. [2013] and limbs... CONCLUSION: The topical suspension containing calcipotriene plus betamethasone
Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a double-blind, randomized, placebo-controlled trial. [2011.05] PURPOSE: To compare the efficacy of three different formulations containing Betamethasone Valerate versus placebo in the topical treatment of phimosis. As a secondary goal, we compared the outcomes after 30 and 60 days of treatment... CONCLUSIONS: Betamethasone Valerate 0.1%, 0.2% and 0.2% in combination with Hyaluronidase had equally higher results than placebo in the treatment of phimosis in boys from three to ten years-old. Patients initially with partial or no response can reach complete response after 60 days of treatment.
Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard. [2011.05] Oral doxepin was shown to reduce chronic pruritus due to sulfur mustard. The present study compared the effects of topical doxepin 5% with betamethasone 1% for the treatment of pruritus in veterans exposed to sulfur mustard...
Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a
double-blind, randomized, placebo-controlled trial. [2011] secondary goal, we compared the outcomes after 30 and 60 days of treatment... CONCLUSIONS: Betamethasone Valerate 0.1%, 0.2% and 0.2% in combination with
Clinical Trials Related to Diprolene AF (Betamethasone Topical)
Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone [Completed]
Particle steroid drug such as triamcinolone has been used widely for epidural steroid
injection (ESI) treatment in Korea. However, Korea FDA recently prohibit ESI using
triamcinolone, following the regulation of US FDA. Therefore, dexamethasone and
betamethasone become only candidate drugs for ESI in Korea and the investigators are curious
about the effectiveness and safety of both drugs due to limitation of information about
comparison of two drugs in previous literature. So, this study aims to compare the
effectiveness and safety of both drugs and our hypothesis is that there is no difference of
the effectiveness between dexamethasone and betamethasone at 2 weeks after ESI.
Effect of Betamethasone Gel and Lidocaine Jelly on Sore Throat, Cough and Hoarseness of [Completed]
ABSTRACT:
The aim of this study was to investigate the effect of betamethasone gel and lidocaine jelly
(over tracheal tube cuff) compared with distilled water on the post intubation syndrome
incidence. This study has not been carried out in Iran.
99 patients of either sex undergoing elective surgery were recruited in a single blind
randomized study. The patients, using randomization table, were divided into three groups.
Anesthetics and medications used during surgery were similar for all the patients.
For the all patients, the incidence of postoperative sore throat, cough and hoarseness of
the voice in the different follow-up periods (1, 6 and 24 hours) based on the different
types of medications were obtained.
Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section [Terminated]
This is a randomized, multicenter, double blind, placebo controlled trial of betamethasone
versus a placebo given prior to the mothers at term and near term gestation (>34 and <40
weeks of gestation) who are scheduled to undergo a planned Cesarean section. The study
design is to determine the efficacy and safety of betamethasone in the prevention of
breathing problems commonly seen in this population.
In infants born by elective Cesarean section, it is hypothesized that antenatal
betamethasone treatment will reduce the risk of neonatal intensive care unit (NICU)
admission from 11% to 8% and/or oxygen therapy +/- positive pressure ventilation (PPV) for
>30 minutes from 4. 5% to 2. 5%.
Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) [Completed]
This study attempts to document the therapeutic value of combining loratadine antihistamine
action (no sedative) with anti-inflammatory effects of betamethasone at low doses, which may
facilitate treatment adherence by patients whereas providing an effective and rapid
perennial allergic rhinitis (PAR) symptoms relief.
Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure [Completed]
Glaucoma is one of the leading causes of blindness worldwide and trabeculectomy is the most
commonly performed operation to slow-down the disease progression. In this study, we compare
the effect of topical cyclosporine A and betamethasone eye drops on the postoperative course
and surgical success of trabeculectomy.
|